Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors

Standard

Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors. / Erarslan-Uysal, Büşra; Kunz, Joachim B; Rausch, Tobias; Richter-Pechańska, Paulina; van Belzen, Ianthe Aem; Frismantas, Viktoras; Bornhauser, Beat; Ordoñez-Rueada, Diana; Paulsen, Malte; Benes, Vladimir; Stanulla, Martin; Schrappe, Martin; Cario, Gunnar; Escherich, Gabriele; Bakharevich, Kseniya; Kirschner-Schwabe, Renate; Eckert, Cornelia; Loukanov, Tsvetomir; Gorenflo, Matthias; Waszak, Sebastian M; Bourquin, Jean-Pierre; Muckenthaler, Martina U; Korbel, Jan O; Kulozik, Andreas E.

In: EMBO MOL MED, Vol. 12, No. 9, 07.09.2020, p. e12104.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Erarslan-Uysal, B, Kunz, JB, Rausch, T, Richter-Pechańska, P, van Belzen, IA, Frismantas, V, Bornhauser, B, Ordoñez-Rueada, D, Paulsen, M, Benes, V, Stanulla, M, Schrappe, M, Cario, G, Escherich, G, Bakharevich, K, Kirschner-Schwabe, R, Eckert, C, Loukanov, T, Gorenflo, M, Waszak, SM, Bourquin, J-P, Muckenthaler, MU, Korbel, JO & Kulozik, AE 2020, 'Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors', EMBO MOL MED, vol. 12, no. 9, pp. e12104. https://doi.org/10.15252/emmm.202012104

APA

Erarslan-Uysal, B., Kunz, J. B., Rausch, T., Richter-Pechańska, P., van Belzen, I. A., Frismantas, V., Bornhauser, B., Ordoñez-Rueada, D., Paulsen, M., Benes, V., Stanulla, M., Schrappe, M., Cario, G., Escherich, G., Bakharevich, K., Kirschner-Schwabe, R., Eckert, C., Loukanov, T., Gorenflo, M., ... Kulozik, A. E. (2020). Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors. EMBO MOL MED, 12(9), e12104. https://doi.org/10.15252/emmm.202012104

Vancouver

Erarslan-Uysal B, Kunz JB, Rausch T, Richter-Pechańska P, van Belzen IA, Frismantas V et al. Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors. EMBO MOL MED. 2020 Sep 7;12(9):e12104. https://doi.org/10.15252/emmm.202012104

Bibtex

@article{0e62bd9b059f4c28a27deddd24c73906,
title = "Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors",
abstract = "We aimed at identifying the developmental stage at which leukemic cells of pediatric T-ALLs are arrested and at defining leukemogenic mechanisms based on ATAC-Seq. Chromatin accessibility maps of seven developmental stages of human healthy T cells revealed progressive chromatin condensation during T-cell maturation. Developmental stages were distinguished by 2,823 signature chromatin regions with 95% accuracy. Open chromatin surrounding SAE1 was identified to best distinguish thymic developmental stages suggesting a potential role of SUMOylation in T-cell development. Deconvolution using signature regions revealed that T-ALLs, including those with mature immunophenotypes, resemble the most immature populations, which was confirmed by TF-binding motif profiles. We integrated ATAC-Seq and RNA-Seq and found DAB1, a gene not related to leukemia previously, to be overexpressed, abnormally spliced and hyper-accessible in T-ALLs. DAB1-negative patients formed a distinct subgroup with particularly immature chromatin profiles and hyper-accessible binding sites for SPI1 (PU.1), a TF crucial for normal T-cell maturation. In conclusion, our analyses of chromatin accessibility and TF-binding motifs showed that pediatric T-ALL cells are most similar to immature thymic precursors, indicating an early developmental arrest.",
author = "B{\"u}{\c s}ra Erarslan-Uysal and Kunz, {Joachim B} and Tobias Rausch and Paulina Richter-Pecha{\'n}ska and {van Belzen}, {Ianthe Aem} and Viktoras Frismantas and Beat Bornhauser and Diana Ordo{\~n}ez-Rueada and Malte Paulsen and Vladimir Benes and Martin Stanulla and Martin Schrappe and Gunnar Cario and Gabriele Escherich and Kseniya Bakharevich and Renate Kirschner-Schwabe and Cornelia Eckert and Tsvetomir Loukanov and Matthias Gorenflo and Waszak, {Sebastian M} and Jean-Pierre Bourquin and Muckenthaler, {Martina U} and Korbel, {Jan O} and Kulozik, {Andreas E}",
note = "{\textcopyright} 2020 The Authors. Published under the terms of the CC BY 4.0 license.",
year = "2020",
month = sep,
day = "7",
doi = "10.15252/emmm.202012104",
language = "English",
volume = "12",
pages = "e12104",
journal = "EMBO MOL MED",
issn = "1757-4676",
publisher = "Wiley-Blackwell",
number = "9",

}

RIS

TY - JOUR

T1 - Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors

AU - Erarslan-Uysal, Büşra

AU - Kunz, Joachim B

AU - Rausch, Tobias

AU - Richter-Pechańska, Paulina

AU - van Belzen, Ianthe Aem

AU - Frismantas, Viktoras

AU - Bornhauser, Beat

AU - Ordoñez-Rueada, Diana

AU - Paulsen, Malte

AU - Benes, Vladimir

AU - Stanulla, Martin

AU - Schrappe, Martin

AU - Cario, Gunnar

AU - Escherich, Gabriele

AU - Bakharevich, Kseniya

AU - Kirschner-Schwabe, Renate

AU - Eckert, Cornelia

AU - Loukanov, Tsvetomir

AU - Gorenflo, Matthias

AU - Waszak, Sebastian M

AU - Bourquin, Jean-Pierre

AU - Muckenthaler, Martina U

AU - Korbel, Jan O

AU - Kulozik, Andreas E

N1 - © 2020 The Authors. Published under the terms of the CC BY 4.0 license.

PY - 2020/9/7

Y1 - 2020/9/7

N2 - We aimed at identifying the developmental stage at which leukemic cells of pediatric T-ALLs are arrested and at defining leukemogenic mechanisms based on ATAC-Seq. Chromatin accessibility maps of seven developmental stages of human healthy T cells revealed progressive chromatin condensation during T-cell maturation. Developmental stages were distinguished by 2,823 signature chromatin regions with 95% accuracy. Open chromatin surrounding SAE1 was identified to best distinguish thymic developmental stages suggesting a potential role of SUMOylation in T-cell development. Deconvolution using signature regions revealed that T-ALLs, including those with mature immunophenotypes, resemble the most immature populations, which was confirmed by TF-binding motif profiles. We integrated ATAC-Seq and RNA-Seq and found DAB1, a gene not related to leukemia previously, to be overexpressed, abnormally spliced and hyper-accessible in T-ALLs. DAB1-negative patients formed a distinct subgroup with particularly immature chromatin profiles and hyper-accessible binding sites for SPI1 (PU.1), a TF crucial for normal T-cell maturation. In conclusion, our analyses of chromatin accessibility and TF-binding motifs showed that pediatric T-ALL cells are most similar to immature thymic precursors, indicating an early developmental arrest.

AB - We aimed at identifying the developmental stage at which leukemic cells of pediatric T-ALLs are arrested and at defining leukemogenic mechanisms based on ATAC-Seq. Chromatin accessibility maps of seven developmental stages of human healthy T cells revealed progressive chromatin condensation during T-cell maturation. Developmental stages were distinguished by 2,823 signature chromatin regions with 95% accuracy. Open chromatin surrounding SAE1 was identified to best distinguish thymic developmental stages suggesting a potential role of SUMOylation in T-cell development. Deconvolution using signature regions revealed that T-ALLs, including those with mature immunophenotypes, resemble the most immature populations, which was confirmed by TF-binding motif profiles. We integrated ATAC-Seq and RNA-Seq and found DAB1, a gene not related to leukemia previously, to be overexpressed, abnormally spliced and hyper-accessible in T-ALLs. DAB1-negative patients formed a distinct subgroup with particularly immature chromatin profiles and hyper-accessible binding sites for SPI1 (PU.1), a TF crucial for normal T-cell maturation. In conclusion, our analyses of chromatin accessibility and TF-binding motifs showed that pediatric T-ALL cells are most similar to immature thymic precursors, indicating an early developmental arrest.

U2 - 10.15252/emmm.202012104

DO - 10.15252/emmm.202012104

M3 - SCORING: Journal article

C2 - 32755029

VL - 12

SP - e12104

JO - EMBO MOL MED

JF - EMBO MOL MED

SN - 1757-4676

IS - 9

ER -